Omega Healthcare Investors OHI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Net margin | 51.1%+1.5pp | 49.6%+2.8pp | 46.8%+4.6pp | 42.2%+0.9pp | 41.3%+2.6pp | |
| EBITDA margin | 98%+0.2pp | 97.9%+1.2pp | 96.6%+4.8pp | 91.8%+0.6pp | 91.2%+1.1pp | |
| Free cash flow margin | 68.2%+1.1pp | 67%-3.2pp | 70.2%+0.4pp | 69.8%+2.6pp | 67.2%-0.5pp | |
| Returns | ||||||
| Return on equity | 12.7%+0.6pp | 12.1%+0.5pp | 11.7%+0.8pp | 10.8%0.0pp | 10.9%+0.8pp | |
| Return on assets | 6.3%+0.4pp | 5.9%+0.6pp | 5.3%+0.5pp | 4.9%+0.1pp | 4.8%+0.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Leverage | ||||||
| Interest coverage | 4.2×+0.2× | 3.9×+0.3× | 3.6×+0.3× | 3.3×+0.1× | 3.1×+0.2× | |
| Valuation | ||||||
| Market capitalization | $12.95B-1.2% | $13.1B+5.2% | $12.45B+16.0% | $10.74B+0.1% | $10.73B+5.0% | |
| Price / earnings | 20.5×-1.7× | 22.2×-0.9× | 23.1×+0.3× | 22.8×-1.1× | 24×-1.2× | |
| Price / sales | 10.5×-0.5× | 11×+0.2× | 10.8×+1.2× | 9.6×-0.3× | 9.9×+0.2× | |
| Price / book | 2.5×0.0× | 2.5×+0.1× | 2.5×+0.3× | 2.2×-0.1× | 2.3×0.0× | |
| Free cash flow yield | 6.5%+0.4pp | 6.1%-0.4pp | 6.5%-0.8pp | 7.2%+0.5pp | 6.8%-0.2pp | |
| Earnings yield | 4.9%+0.4pp | 4.5%+0.2pp | 4.3%-0.1pp | 4.4%+0.2pp | 4.2%+0.2pp | |
| Dividend yield | 6.1%+0.1pp | 6%-0.2pp | 6.1%-0.7pp | 6.9%+0.3pp | 6.6%-0.1pp | |
| PEG ratio | 0.5×0.0× | 0.5×+0.1× | 0.4×-0.1× | 0.5×+0.1× | 0.4×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Omega Healthcare Investors's ratios come from?
- Every ratio is computed from Omega Healthcare Investors's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
